Structural studies of neutral amino acid transporters of the SLC6 family coupled with discovery of new inhibitors — The Association Specialists

Structural studies of neutral amino acid transporters of the SLC6 family coupled with discovery of new inhibitors (21395)

Jedrzej Kukulowicz 1 , Angelika Broer 2 , Ziwei Hu 3 , Aditya Yadav 2 , Ting Zhang 3 , Lu Dai 3 , Renhong Yan 3 , Stefan Broer 2 , Marek Bajda 1
  1. Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland
  2. Research School of Biology, Australian National University, Canberra, ACT, Australia
  3. Department of Biochemistry, Key University Laboratory of Metabolism and Health of Guangdong, School of Medicine, Institute for Biological Electron Microscopy, Southern University of Science and Technology, Shenzhen, Guangdong, China

Sodium-dependent membrane transporters of the SLC6 family mediate the transport of amino acids and monoamines. Their neural representatives, such as B0AT2 (SLC6A15), NTT4 (SLC6A17), and SIT1 (SLC6A20), transport neutral amino acids and thereby maintain glutaminergic homeostasis by supplying neurons and glial cells with precursors for the glutamine-glutamate-GABA cycle. Their dysfunction has been associated with anxiety, mental retardation, or NMDA receptor hypofunction 1. The structures of these transporters are poorly understood and remain an area of research. In doing so, we carried out computational investigations followed by cryo-EM and kinetic studies. As a result, we have collected data that advance our understanding of the structure, membrane anchoring, mechanism of substrate transport and inhibition. Fine feedback, with the discovery of first-in-class potent inhibitors of B0AT2 and SIT1, has validated our computational methods. Our findings will guide further structural studies toward a mechanistic understanding of transporter function.  Furthermore, the discovery of new inhibitors will also be an aid in the design of another. Such a compounds will be useful for investigating the therapeutic relevance of their targets as well as for deciphering the physiology of the glutaminergic system.

  1. Kukułowicz J, Pietrzak-Lichwa K, Klimończyk K, Idlin N, Bajda M. The SLC6A15-SLC6A20 Neutral Amino Acid Transporter Subfamily: Functions, Diseases, and Their Therapeutic Relevance. Pharmacol Rev. 2023;76(1):142-193. 2023 Dec 15. doi:10.1124/pharmrev.123.000886